Cargando…

In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model

BACKGROUND: A series of human diseases are caused by the misfolding and aggregation of specific proteins or peptides into amyloid fibrils; nine of these diseases, referred to as polyglutamine diseases, are associated with proteins carrying an expanded polyglutamine (polyQ) region. While the presence...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Assche, Roel, Borghgraef, Charline, Vaneyck, Jonathan, Dumoulin, Mireille, Schoofs, Liliane, Temmerman, Liesbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568214/
https://www.ncbi.nlm.nih.gov/pubmed/28830560
http://dx.doi.org/10.1186/s12952-017-0080-5
_version_ 1783258814901911552
author Van Assche, Roel
Borghgraef, Charline
Vaneyck, Jonathan
Dumoulin, Mireille
Schoofs, Liliane
Temmerman, Liesbet
author_facet Van Assche, Roel
Borghgraef, Charline
Vaneyck, Jonathan
Dumoulin, Mireille
Schoofs, Liliane
Temmerman, Liesbet
author_sort Van Assche, Roel
collection PubMed
description BACKGROUND: A series of human diseases are caused by the misfolding and aggregation of specific proteins or peptides into amyloid fibrils; nine of these diseases, referred to as polyglutamine diseases, are associated with proteins carrying an expanded polyglutamine (polyQ) region. While the presence of this latter is thought to be the determinant factor for the development of polyQ diseases, the non-polyQ regions of the host proteins are thought to play a significant modulating role. METHOD: In order to better understand the role of non-polyQ regions, the toxic effects of model proteins bearing different polyQ regions (containing up to 79 residues) embedded at two distinct locations within the β-lactamase (BlaP) host enzyme were evaluated in Caenorhabditis elegans. This small organism can be advantageous for the validation of in vitro findings, as it provides a multicellular context yet avoids the typical complexity of common studies relying on vertebrate models. Several phenotypic assays were performed in order to screen for potential toxic effects of the different BlaP-polyQ proteins. RESULTS: Despite the significant in vitro aggregation of BlaP-polyQ proteins with long polyQ regions, none of the BlaP-polyQ chimeras aggregated in the generated transgenic in vivo models. CONCLUSION: The absence of a toxic effect of the expression of BlaP-polyQ chimeras may find its cause in biochemical mechanisms present in vivo to cope with protein aggregation (e.g. presence of chaperones) or in C. elegans’ limitations such as its short lifespan. It is plausible that the aggregation propensities of the different BlaP chimeras containing embedded polyQ sequences are too low in this in vivo environment to permit their aggregation. These experiments emphasize the need for several comparative and in vivo verification studies of biologically relevant in vitro findings, which reveal both the strengths and limitations of widely used model systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12952-017-0080-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5568214
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55682142017-08-29 In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model Van Assche, Roel Borghgraef, Charline Vaneyck, Jonathan Dumoulin, Mireille Schoofs, Liliane Temmerman, Liesbet J Negat Results Biomed Research BACKGROUND: A series of human diseases are caused by the misfolding and aggregation of specific proteins or peptides into amyloid fibrils; nine of these diseases, referred to as polyglutamine diseases, are associated with proteins carrying an expanded polyglutamine (polyQ) region. While the presence of this latter is thought to be the determinant factor for the development of polyQ diseases, the non-polyQ regions of the host proteins are thought to play a significant modulating role. METHOD: In order to better understand the role of non-polyQ regions, the toxic effects of model proteins bearing different polyQ regions (containing up to 79 residues) embedded at two distinct locations within the β-lactamase (BlaP) host enzyme were evaluated in Caenorhabditis elegans. This small organism can be advantageous for the validation of in vitro findings, as it provides a multicellular context yet avoids the typical complexity of common studies relying on vertebrate models. Several phenotypic assays were performed in order to screen for potential toxic effects of the different BlaP-polyQ proteins. RESULTS: Despite the significant in vitro aggregation of BlaP-polyQ proteins with long polyQ regions, none of the BlaP-polyQ chimeras aggregated in the generated transgenic in vivo models. CONCLUSION: The absence of a toxic effect of the expression of BlaP-polyQ chimeras may find its cause in biochemical mechanisms present in vivo to cope with protein aggregation (e.g. presence of chaperones) or in C. elegans’ limitations such as its short lifespan. It is plausible that the aggregation propensities of the different BlaP chimeras containing embedded polyQ sequences are too low in this in vivo environment to permit their aggregation. These experiments emphasize the need for several comparative and in vivo verification studies of biologically relevant in vitro findings, which reveal both the strengths and limitations of widely used model systems. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12952-017-0080-5) contains supplementary material, which is available to authorized users. BioMed Central 2017-08-22 /pmc/articles/PMC5568214/ /pubmed/28830560 http://dx.doi.org/10.1186/s12952-017-0080-5 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Van Assche, Roel
Borghgraef, Charline
Vaneyck, Jonathan
Dumoulin, Mireille
Schoofs, Liliane
Temmerman, Liesbet
In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model
title In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model
title_full In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model
title_fullStr In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model
title_full_unstemmed In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model
title_short In vitro aggregating β-lactamase-polyQ chimeras do not induce toxic effects in an in vivo Caenorhabditis elegans model
title_sort in vitro aggregating β-lactamase-polyq chimeras do not induce toxic effects in an in vivo caenorhabditis elegans model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568214/
https://www.ncbi.nlm.nih.gov/pubmed/28830560
http://dx.doi.org/10.1186/s12952-017-0080-5
work_keys_str_mv AT vanasscheroel invitroaggregatingblactamasepolyqchimerasdonotinducetoxiceffectsinaninvivocaenorhabditiselegansmodel
AT borghgraefcharline invitroaggregatingblactamasepolyqchimerasdonotinducetoxiceffectsinaninvivocaenorhabditiselegansmodel
AT vaneyckjonathan invitroaggregatingblactamasepolyqchimerasdonotinducetoxiceffectsinaninvivocaenorhabditiselegansmodel
AT dumoulinmireille invitroaggregatingblactamasepolyqchimerasdonotinducetoxiceffectsinaninvivocaenorhabditiselegansmodel
AT schoofsliliane invitroaggregatingblactamasepolyqchimerasdonotinducetoxiceffectsinaninvivocaenorhabditiselegansmodel
AT temmermanliesbet invitroaggregatingblactamasepolyqchimerasdonotinducetoxiceffectsinaninvivocaenorhabditiselegansmodel